# Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

> **NCT07034677** · PHASE4 · RECRUITING · sponsor: **Lars Rejnmark** · enrollment: 24 (estimated)

## Conditions studied

- Hypoparathyroidism Post-surgical

## Interventions

- **DRUG:** Indapamide 1.5 MG SR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07034677
- **Lead sponsor:** Lars Rejnmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034677, "Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07034677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*